Acute kidney injury outcomes in covid-19 patients: systematic review and meta-analysis

Detalhes bibliográficos
Autor(a) principal: Silva,Beatriz Moreira
Data de Publicação: 2022
Outros Autores: Assis,Letícia Cristina Silva De, Batista Júnior,Maurício De Castro, Gonzalez,Naara Affonso Philipps, Anjos,Samuel Benni Dos, Goes,Miguel Angelo
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Jornal Brasileiro de Nefrologia
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002022005038401
Resumo: Abstract Background: Acute kidney injury (AKI) is a frequent complication of coronavirus-19 disease (COVID-19). Therefore, we decided to perform a systematic review and meta-analysis with data from the literature to relate the development of COVID-19 associated-AKI with comorbidities, medications, and the impact of mechanical ventilation. Methods: We performed a systematic review using the Newcastle-Ottawa scale and a meta-analysis using the R program. Relevant studies were searched in the PubMed, Medline, and SciELO electronic databases. Search filters were used to include reports after 2020 and cohort studies. Results: In total, 1166 articles were identified and 55 English-written articles were included based on the risk of bias. Of all COVID-19-hospitalized patients presenting with AKI (n = 18029) classified as Kidney Disease Improving Global Outcomes stage 1 to 3, approximately 18% required mechanical ventilation and 39.2 % died. Around 11.3% of the patients required kidney replacement therapy (KRT) and of these, 1093 died and 321 required continuous KRT. Death is more frequent in individuals with AKI [OR 6.03, 95%CI: 5.73-6.74; p<0.01]. Finally, mechanical ventilation is an aggravating factor in the clinical conditions studied [OR 11.01, 95%CI: 10.29-11.77; p<0.01]. Conclusion: Current literature indicates AKI as an important complication in COVID-19. In this context, we observed that comorbidities, such as chronic kidney disease and heart failure, were more related to the development of AKI. In addition, mechanical ventilation was seen as an aggravating factor in this scenario.
id SBN-1_febefd169978f60a20caad3a7a6f3824
oai_identifier_str oai:scielo:S0101-28002022005038401
network_acronym_str SBN-1
network_name_str Jornal Brasileiro de Nefrologia
repository_id_str
spelling Acute kidney injury outcomes in covid-19 patients: systematic review and meta-analysisSARS-CoV-2COVID-19Acute Kidney InjuryRenal Replacement TherapyAbstract Background: Acute kidney injury (AKI) is a frequent complication of coronavirus-19 disease (COVID-19). Therefore, we decided to perform a systematic review and meta-analysis with data from the literature to relate the development of COVID-19 associated-AKI with comorbidities, medications, and the impact of mechanical ventilation. Methods: We performed a systematic review using the Newcastle-Ottawa scale and a meta-analysis using the R program. Relevant studies were searched in the PubMed, Medline, and SciELO electronic databases. Search filters were used to include reports after 2020 and cohort studies. Results: In total, 1166 articles were identified and 55 English-written articles were included based on the risk of bias. Of all COVID-19-hospitalized patients presenting with AKI (n = 18029) classified as Kidney Disease Improving Global Outcomes stage 1 to 3, approximately 18% required mechanical ventilation and 39.2 % died. Around 11.3% of the patients required kidney replacement therapy (KRT) and of these, 1093 died and 321 required continuous KRT. Death is more frequent in individuals with AKI [OR 6.03, 95%CI: 5.73-6.74; p<0.01]. Finally, mechanical ventilation is an aggravating factor in the clinical conditions studied [OR 11.01, 95%CI: 10.29-11.77; p<0.01]. Conclusion: Current literature indicates AKI as an important complication in COVID-19. In this context, we observed that comorbidities, such as chronic kidney disease and heart failure, were more related to the development of AKI. In addition, mechanical ventilation was seen as an aggravating factor in this scenario.Sociedade Brasileira de Nefrologia2022-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002022005038401Brazilian Journal of Nephrology n.ahead 2022reponame:Jornal Brasileiro de Nefrologiainstname:Sociedade Brasileira de Nefrologia (SBN)instacron:SBN10.1590/2175-8239-jbn-2022-0013eninfo:eu-repo/semantics/openAccessSilva,Beatriz MoreiraAssis,Letícia Cristina Silva DeBatista Júnior,Maurício De CastroGonzalez,Naara Affonso PhilippsAnjos,Samuel Benni DosGoes,Miguel Angeloeng2022-07-13T00:00:00Zoai:scielo:S0101-28002022005038401Revistahttp://www.bjn.org.br/ONGhttps://old.scielo.br/oai/scielo-oai.php||jbn@sbn.org.br2175-82390101-2800opendoar:2022-07-13T00:00Jornal Brasileiro de Nefrologia - Sociedade Brasileira de Nefrologia (SBN)false
dc.title.none.fl_str_mv Acute kidney injury outcomes in covid-19 patients: systematic review and meta-analysis
title Acute kidney injury outcomes in covid-19 patients: systematic review and meta-analysis
spellingShingle Acute kidney injury outcomes in covid-19 patients: systematic review and meta-analysis
Silva,Beatriz Moreira
SARS-CoV-2
COVID-19
Acute Kidney Injury
Renal Replacement Therapy
title_short Acute kidney injury outcomes in covid-19 patients: systematic review and meta-analysis
title_full Acute kidney injury outcomes in covid-19 patients: systematic review and meta-analysis
title_fullStr Acute kidney injury outcomes in covid-19 patients: systematic review and meta-analysis
title_full_unstemmed Acute kidney injury outcomes in covid-19 patients: systematic review and meta-analysis
title_sort Acute kidney injury outcomes in covid-19 patients: systematic review and meta-analysis
author Silva,Beatriz Moreira
author_facet Silva,Beatriz Moreira
Assis,Letícia Cristina Silva De
Batista Júnior,Maurício De Castro
Gonzalez,Naara Affonso Philipps
Anjos,Samuel Benni Dos
Goes,Miguel Angelo
author_role author
author2 Assis,Letícia Cristina Silva De
Batista Júnior,Maurício De Castro
Gonzalez,Naara Affonso Philipps
Anjos,Samuel Benni Dos
Goes,Miguel Angelo
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Silva,Beatriz Moreira
Assis,Letícia Cristina Silva De
Batista Júnior,Maurício De Castro
Gonzalez,Naara Affonso Philipps
Anjos,Samuel Benni Dos
Goes,Miguel Angelo
dc.subject.por.fl_str_mv SARS-CoV-2
COVID-19
Acute Kidney Injury
Renal Replacement Therapy
topic SARS-CoV-2
COVID-19
Acute Kidney Injury
Renal Replacement Therapy
description Abstract Background: Acute kidney injury (AKI) is a frequent complication of coronavirus-19 disease (COVID-19). Therefore, we decided to perform a systematic review and meta-analysis with data from the literature to relate the development of COVID-19 associated-AKI with comorbidities, medications, and the impact of mechanical ventilation. Methods: We performed a systematic review using the Newcastle-Ottawa scale and a meta-analysis using the R program. Relevant studies were searched in the PubMed, Medline, and SciELO electronic databases. Search filters were used to include reports after 2020 and cohort studies. Results: In total, 1166 articles were identified and 55 English-written articles were included based on the risk of bias. Of all COVID-19-hospitalized patients presenting with AKI (n = 18029) classified as Kidney Disease Improving Global Outcomes stage 1 to 3, approximately 18% required mechanical ventilation and 39.2 % died. Around 11.3% of the patients required kidney replacement therapy (KRT) and of these, 1093 died and 321 required continuous KRT. Death is more frequent in individuals with AKI [OR 6.03, 95%CI: 5.73-6.74; p<0.01]. Finally, mechanical ventilation is an aggravating factor in the clinical conditions studied [OR 11.01, 95%CI: 10.29-11.77; p<0.01]. Conclusion: Current literature indicates AKI as an important complication in COVID-19. In this context, we observed that comorbidities, such as chronic kidney disease and heart failure, were more related to the development of AKI. In addition, mechanical ventilation was seen as an aggravating factor in this scenario.
publishDate 2022
dc.date.none.fl_str_mv 2022-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002022005038401
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002022005038401
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/2175-8239-jbn-2022-0013en
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Nefrologia
publisher.none.fl_str_mv Sociedade Brasileira de Nefrologia
dc.source.none.fl_str_mv Brazilian Journal of Nephrology n.ahead 2022
reponame:Jornal Brasileiro de Nefrologia
instname:Sociedade Brasileira de Nefrologia (SBN)
instacron:SBN
instname_str Sociedade Brasileira de Nefrologia (SBN)
instacron_str SBN
institution SBN
reponame_str Jornal Brasileiro de Nefrologia
collection Jornal Brasileiro de Nefrologia
repository.name.fl_str_mv Jornal Brasileiro de Nefrologia - Sociedade Brasileira de Nefrologia (SBN)
repository.mail.fl_str_mv ||jbn@sbn.org.br
_version_ 1752122067676823552